A carregar...
CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia
Although human genetics has resulted in the identification of novel lipid-related genes that can be targeted for the prevention of atherosclerotic vascular disease, medications targeting these genes or their protein products have short-term effects and require frequent administration during the cour...
Na minha lista:
| Publicado no: | Arterioscler Thromb Vasc Biol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5832026/ https://ncbi.nlm.nih.gov/pubmed/28838920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.117.309326 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|